145 related articles for article (PubMed ID: 20214982)
1. Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: promising new therapeutic targets?
Sertznig P; Seifert M; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):383-6. PubMed ID: 20214982
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
3. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
Sertznig P; Seifert M; Tilgen W; Reichrath J
J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
[TBL] [Abstract][Full Text] [Related]
4. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
6. Activation of vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)(2)D(3) in melanoma cell lines and other skin-derived cell lines.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Dermatoendocrinol; 2009 Jul; 1(4):232-8. PubMed ID: 20592797
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor and vitamin d receptor signaling pathways in cancer cells.
Matsuda S; Kitagishi Y
Cancers (Basel); 2013 Oct; 5(4):1261-70. PubMed ID: 24202445
[TBL] [Abstract][Full Text] [Related]
8. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
9. Methyl donor deficiency impairs bone development via peroxisome proliferator-activated receptor-γ coactivator-1α-dependent vitamin D receptor pathway.
Feigerlova E; Demarquet L; Melhem H; Ghemrawi R; Battaglia-Hsu SF; Ewu E; Alberto JM; Helle D; Weryha G; Guéant JL
FASEB J; 2016 Oct; 30(10):3598-3612. PubMed ID: 27435264
[TBL] [Abstract][Full Text] [Related]
10. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
11. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.
Gardner OS; Dewar BJ; Graves LM
Mol Pharmacol; 2005 Oct; 68(4):933-41. PubMed ID: 16020742
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
Evans SR; Houghton AM; Schumaker L; Brenner RV; Buras RR; Davoodi F; Nauta RJ; Shabahang M
J Surg Res; 1996 Feb; 61(1):127-33. PubMed ID: 8769954
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D-VDR Signaling Inhibits Wnt/β-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Muralidhar S; Filia A; Nsengimana J; Poźniak J; O'Shea SJ; Diaz JM; Harland M; Randerson-Moor JA; Reichrath J; Laye JP; van der Weyden L; Adams DJ; Bishop DT; Newton-Bishop J
Cancer Res; 2019 Dec; 79(23):5986-5998. PubMed ID: 31690667
[TBL] [Abstract][Full Text] [Related]
15. Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells.
Takeda M; Otsuka F; Otani H; Inagaki K; Miyoshi T; Suzuki J; Mimura Y; Ogura T; Makino H
J Endocrinol; 2007 Jul; 194(1):87-99. PubMed ID: 17592024
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
Aleshin S; Strokin M; Sergeeva M; Reiser G
Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation.
Lin YM; Sun HY; Chiu WT; Su HC; Chien YC; Chong LW; Chang HC; Bai CH; Young KC; Tsao CW
Viruses; 2018 Jan; 10(2):. PubMed ID: 29385741
[TBL] [Abstract][Full Text] [Related]
18. PPARs and the Kynurenine Pathway in Melanoma-Potential Biological Interactions.
Walczak K; Gerkowicz A; Krasowska D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834531
[TBL] [Abstract][Full Text] [Related]
19. [A trip through the signaling pathways of melanoma].
Fensterle J
J Dtsch Dermatol Ges; 2006 Mar; 4(3):205-17. PubMed ID: 16626317
[TBL] [Abstract][Full Text] [Related]
20. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
